Arterial Spin Labeling (ASL) in Neuroradiological Diagnostics – Methodological Overview and Use Cases
Nico Sollmann,Gabriel Hoffmann,Severin Schramm,Miriam Reichert,Moritz Hernandez Petzsche,Joachim Strobel,Lorenzo Nigris,Christopher Kloth,Johannes Rosskopf,Corinna Börner,Michaela Bonfert,Maria Berndt,Georg Grön,Hans-Peter Müller,Jan Kassubek,Kornelia Kreiser,Inga K. Koerte,Hans Liebl,Ambros Beer,Claus Zimmer,Meinrad Beer,Stephan Kaczmarz
DOI: https://doi.org/10.1055/a-2119-5574
2023-07-21
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
Abstract:Background Arterial spin labeling (ASL) is a magnetic resonance imaging (MRI)-based technique using labeled blood-water of the brain-feeding arteries as an endogenous tracer to derive information about brain perfusion. It enables the assessment of cerebral blood flow (CBF). Method This review aims to provide a methodological and technical overview of ASL techniques, and to give examples of clinical use cases for various diseases affecting the central nervous system (CNS). There is a special focus on recent developments including super-selective ASL (ssASL) and time-resolved ASL-based magnetic resonance angiography (MRA) and on diseases commonly not leading to characteristic alterations on conventional structural MRI (e. g., concussion or migraine). Results ASL-derived CBF may represent a clinically relevant parameter in various pathologies such as cerebrovascular diseases, neoplasms, or neurodegenerative diseases. Furthermore, ASL has also been used to investigate CBF in mild traumatic brain injury or migraine, potentially leading to the establishment of imaging-based biomarkers. Recent advances made possible the acquisition of ssASL by selective labeling of single brain-feeding arteries, enabling spatial perfusion territory mapping dependent on blood flow of a specific preselected artery. Furthermore, ASL-based MRA has been introduced, providing time-resolved delineation of single intracranial vessels. Conclusion Perfusion imaging by ASL has shown promise in various diseases of the CNS. Given that ASL does not require intravenous administration of a gadolinium-based contrast agent, it may be of particular interest for investigations in pediatric cohorts, patients with impaired kidney function, patients with relevant allergies, or patients that undergo serial MRI for clinical indications such as disease monitoring. Key Points:
radiology, nuclear medicine & medical imaging